Back to top
more

Acumen Pharmaceuticals (ABOS)

(Real Time Quote from BATS)

$3.22 USD

3.22
168,047

+0.05 (1.42%)

Updated Apr 23, 2024 02:03 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 252)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Why Acumen Pharmaceuticals (ABOS) Stock Might be a Great Pick

Acumen Pharmaceuticals (ABOS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Acumen Pharmaceuticals (ABOS) Upgraded to Buy: What Does It Mean for the Stock?

Acumen Pharmaceuticals (ABOS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is Acumen Pharmaceuticals (ABOS) Outperforming Other Medical Stocks This Year?

Here is how Acumen Pharmaceuticals, Inc. (ABOS) and Ayr Wellness Inc. (AYRWF) have performed compared to their sector so far this year.

Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year?

Here is how Acumen Pharmaceuticals, Inc. (ABOS) and Akoya Biosciences (AKYA) have performed compared to their sector so far this year.

Are Medical Stocks Lagging Acumen Pharmaceuticals (ABOS) This Year?

Here is how Acumen Pharmaceuticals, Inc. (ABOS) and Haemonetics (HAE) have performed compared to their sector so far this year.

Is Novo Nordisk (NVO) Stock Outpacing Its Medical Peers This Year?

Here is how Novo Nordisk (NVO) and Acumen Pharmaceuticals, Inc. (ABOS) have performed compared to their sector so far this year.

Philips' (PHG) Innovative Product Suite to Cheer Investors

Philips (PHG) launches two major cardiological innovations at ACC 2022, adding strength and depth to its existing healthcare portfolio.

Philips' (PHG) Lung Suite 3D Imaging Solution Gains Traction

Philips' (PHG) innovative lung cancer diagnosis and treatment solution, Philips Lung Suite, is witnessing rapid adoption by clinical partners globally

Philips (PHG) Ties Up With Nuvo Group to Boost Maternal Care

Philips (PHG) collaborates with Nuvo to develop maternity care services with digital solutions and eco-system building in rural areas

Philips' (PHG) Collaboration Live Gets Nod for Remote Diagnosis

Koninklijke Philips' (PHG) Collaboration Live integrated tele-ultrasound receives the expanded U.S. Food & Drug Administration 510(k) clearance for remote diagnostic use on additional mobile platforms.